Drug Development Life Cycle
Drug authentication is generally governed by critical procedures. This book presents a comprehensive overview of drug design, highlighting the steps involved from the discovery phase to product approval. Chapters address such topics as drug development processes, pharmaceutical nanoformulations and...
Saved in:
| Other Authors: | , , |
|---|---|
| Format: | Electronic Book Chapter |
| Language: | English |
| Published: |
IntechOpen
2022
|
| Subjects: | |
| Online Access: | DOAB: download the publication DOAB: description of the publication |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
| LEADER | 00000naaaa2200000uu 4500 | ||
|---|---|---|---|
| 001 | doab_20_500_12854_97251 | ||
| 005 | 20230215 | ||
| 003 | oapen | ||
| 006 | m o d | ||
| 007 | cr|mn|---annan | ||
| 008 | 20230215s2022 xx |||||o ||| 0|eng d | ||
| 020 | |a intechopen.96842 | ||
| 020 | |a 9781803560489 | ||
| 020 | |a 9781803560472 | ||
| 020 | |a 9781803560496 | ||
| 040 | |a oapen |c oapen | ||
| 024 | 7 | |a 10.5772/intechopen.96842 |c doi | |
| 041 | 0 | |a eng | |
| 042 | |a dc | ||
| 072 | 7 | |a MMG |2 bicssc | |
| 100 | 1 | |a Akhtar, Juber |4 edt | |
| 700 | 1 | |a Ahmad, Mohammad |4 edt | |
| 700 | 1 | |a Irfan Khan, Mohammad |4 edt | |
| 700 | 1 | |a Akhtar, Juber |4 oth | |
| 700 | 1 | |a Ahmad, Mohammad |4 oth | |
| 700 | 1 | |a Irfan Khan, Mohammad |4 oth | |
| 245 | 1 | 0 | |a Drug Development Life Cycle |
| 260 | |b IntechOpen |c 2022 | ||
| 300 | |a 1 electronic resource (110 p.) | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 506 | 0 | |a Open Access |2 star |f Unrestricted online access | |
| 520 | |a Drug authentication is generally governed by critical procedures. This book presents a comprehensive overview of drug design, highlighting the steps involved from the discovery phase to product approval. Chapters address such topics as drug development processes, pharmaceutical nanoformulations and cosmeceuticals for topical use, ocular drug delivery systems, and drug development involving computer-aided drug design, machine learning, and artificial intelligence. | ||
| 540 | |a Creative Commons |f https://creativecommons.org/licenses/by/3.0/ |2 cc |4 https://creativecommons.org/licenses/by/3.0/ | ||
| 546 | |a English | ||
| 650 | 7 | |a Pharmacology |2 bicssc | |
| 653 | |a Other branches of medicine | ||
| 856 | 4 | 0 | |a www.oapen.org |u https://mts.intechopen.com/storage/books/11091/authors_book/authors_book.pdf |7 0 |z DOAB: download the publication |
| 856 | 4 | 0 | |a www.oapen.org |u https://directory.doabooks.org/handle/20.500.12854/97251 |7 0 |z DOAB: description of the publication |